Delivery Order SPE2DB22D3301-SPE2DB24FY0PF

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.49, is a delivery order for the supply of 4,567,132,259 vials of Cefazolin 1 GM, a generic antibiotic medication. The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,924,778 units of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The order has a ceiling value of $1,445.28 and is a firm fixed-price contract. The ultimate completion date for this delivery order is September 25, 2024. This award is not a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,613.20 order is for the supply of 4,564,075,904 units of the pharmaceutical product cefazolin 2 g/50 ml-dextrose. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,550 units of the pharmaceutical product Cefazolin 2 g/50 mL-Dextroses. The contract, valued at $7,257.47, has an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation located in Conshohocken, Pennsylvania. The $1,024.86 order is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,662,455 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract has a ceiling value of $15,175.44 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,670.43 delivery order is for the provision of Cefazolin 2 G/50 ML-Dextroses, a commonly prescribed antibiotic medication. The contract is a firm fixed-price delivery order that does not have a set-aside designation. It is part of...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $2,167.92, is for the supply of 4,564,083,639 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,702,508 units of the pharmaceutical product Cefazolin 1 Gram Vials. The contract has a ceiling value of $1,218.70 and a period of performance through May 24, 2024. This contract is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,529.24 firm fixed-price contract is for the supply of cefazolin 2 g/50 ml dextrose, a critical intravenous antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY0PF
    Delivery Order

This is a $1,195.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,633,005 vials of Cefazolin 1 GM, a broad-spectrum antibiotic used to treat various bacterial infections. The delivery order has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00, to provide pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. This specific delivery order was issued against that larger contract vehicle, which does not have a set-aside designation.

Generated 5/13/24, 9:41 AM